Monoclonal antibodies have been instrumental in treating infectious diseases, including those caused by the Zika virus, the Ebola virus, and most recently, SARS-CoV-2. Since their discovery in the 1970s, scientists have developed improved approaches to identify, select, optimize, and manufacture monoclonal antibodies. This webinar will examine ways that scientists discover and use monoclonal antibodies for the treatment of infectious diseases and discuss exciting developments in monoclonal antibody research.
Topics to be covered
James E. Crowe, Jr., MD, PhD
Director, Vanderbilt Vaccine Center
Professor, Pediatrics and Pathology, Microbiology and Immunology
Ann Scott Carrell Chair
Interested in sponsoring a webinar?
Click here to contact our friendly sales team.